RecruitingNot ApplicableNCT07351747

Effect of Laser Acupoints on Fallopian Tube Obstruction


Sponsor

Kafrelsheikh University

Enrollment

36 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to determine the efficacy of laser acupoint therapy on treating fallopian tube obstruction.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 35 Years

Inclusion Criteria7

  • Women aged 20-35 years - nulliparous.
  • Women diagnosed with fallopian tube obstruction.
  • Body mass index less than 30 kg/m2.
  • Consent to participate in the study.
  • General good health with no major co-existing medical conditions that could interfere with the treatment or outcomes.
  • No prior fertility treatments \[e.g., In vitro fertilization (IVF), intrauterine insemination (IUI)\] within the last 6 months.
  • Ability to attend all scheduled sessions and follow-up assessments.

Exclusion Criteria8

  • Currently pregnant or breastfeeding.
  • History of pelvic surgery within the past year.
  • Presence of severe systemic diseases such as active cancer or severe cardiovascular diseases.
  • History of allergic reactions or adverse responses to acupuncture or laser therapies.
  • Currently undergoing hormonal therapy or use of hormonal contraceptives.
  • Current or recent history of genital tract infections, including sexually transmitted. infections, which could affect the reproductive system.
  • Presence of significant uterine anomalies diagnosed through imaging that could impact fertility.
  • Polycystic Ovary Syndrome (PCOS).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLaser acupoints therapy + Standard care

Patients will receive laser acupoints therapy addition to standard care.

OTHERStandard care

Patients will receive placebo laser acupoints therapy in addition to standard care.


Locations(1)

Kafrelsheikh University (Faculty of Physical Therapy)

Kafr ash Shaykh, Kafrelsheikh, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07351747


Related Trials